Hepatic encephalopathy
Top View
- Acute Cholangitis: Does the Timing of ERCP Alter Outcomes?
- A Review of Budd Chiari Syndrome
- PBC Primary Biliary Cholangitis Treatment and Management
- Living with Hepatic Encephalopathy (HE) What Is Hepatic Encephalopathy (HE)?
- Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Dise
- A Case of Acute Liver Failure After Adenovirus Infection
- Crohn's Disease
- Hepatic Encephalopathy: Etiology, Pathogenesis, and Clinical Signs
- Hepatic Encephalopathy (HE)
- PRIOR AUTHORIZATION CRITERIA BRAND NAME (Generic) XIFAXAN 550MG ONLY (Rifaximin)
- Impact of Liver and Pancreas Diseases on Nutritional Status
- Rifaximin (Xifaxan) for Irritable Bowel Syndrome
- Rifaximin (Xifaxan®)
- Nonalcoholic Cirrhosis Associated with Neuropsychological Dysfunction in the Absence of Overt Evidence of Hepatic Encephalopathy
- Diagnosis and Management of Hepatic Encephalopathy
- Antibiotics : Anti-Infective Agents – Oral Rifaximin (Xifaxan®) Medical Policy No
- The Burden of Minimal Hepatic Encephalopathy: from Diagnosis to Therapeutic Strategies
- EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosisq